Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01236534 · ClinicalTrials.gov registry record · Phase 4

Lubiprostone in Patients With Multiple Sclerosis Associated Constipation

A Phase 4 study of Multiple Sclerosis and Constipation, sponsored by University of Rochester.

Completed
Registry status
Phase 4
Development phase
21
Enrollment target
1
Study location

NCT01236534 is a Phase 4 study of Multiple Sclerosis and Constipation that has completed, run by University of Rochester. The registered enrollment target is 21 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01236534, a Phase 4 study of Multiple Sclerosis and Constipation, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 4
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to assess how safe and effective the drug Lubiprostone is in people with Multiple Sclerosis (MS)and moderate to severe MS-associated constipation. Lubiprostone is approved by the FDA for the treatment of two common types of constipation in adults, chronic idiopathic constipation and irritable bowel syndrome.

Conditions Studied

Multiple Sclerosis Constipation

Interventions

  • DRUG Placebo
  • DRUG Lubiprostone

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2010-11
Est. Completion 2012-04
Phase Phase 4

Sponsor

University of Rochester

636 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01236534

The ClinicalTrials.gov registry entry for NCT01236534 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (96% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01236534 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01236534 about?

NCT01236534 is a clinical study titled "Lubiprostone in Patients With Multiple Sclerosis Associated Constipation". The purpose of the study is to assess how safe and effective the drug Lubiprostone is in people with Multiple Sclerosis (MS)and moderate to severe MS-associated constipation. Lubiprostone is approved by the FDA for the treatment of two common types of constipation in adults, chronic idiopathic const...

What is the current status of trial NCT01236534?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2010-11. Estimated completion is 2012-04.

What conditions does trial NCT01236534 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Constipation.

What interventions are being tested in trial NCT01236534?

The interventions under investigation include: Placebo (DRUG), Lubiprostone (DRUG).

Who is sponsoring clinical trial NCT01236534?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01236534 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Constipation

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.